Annual Short Term Debt
$1.61 M
+$169.00 K+11.70%
December 31, 2023
Summary
- As of February 8, 2025, CLDX annual short term debt is $1.61 million, with the most recent change of +$169.00 thousand (+11.70%) on December 31, 2023.
- During the last 3 years, CLDX annual short term debt has risen by +$287.00 thousand (+21.63%).
- CLDX annual short term debt is now -73.70% below its all-time high of $6.14 million, reached on December 31, 2011.
Performance
CLDX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$1.38 M
-$210.00 K-13.22%
September 1, 2024
Summary
- As of February 8, 2025, CLDX quarterly short term debt is $1.38 million, with the most recent change of -$210.00 thousand (-13.22%) on September 1, 2024.
- Over the past year, CLDX quarterly short term debt has dropped by -$235.00 thousand (-14.56%).
- CLDX quarterly short term debt is now -99.66% below its all-time high of $401.00 million, reached on September 30, 1997.
Performance
CLDX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
CLDX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.7% | -14.6% |
| 3 y3 years | +21.6% | +0.9% |
| 5 y5 years | +100.0% | -38.8% |
CLDX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.6% | +11.7% | -23.5% | at low |
| 5 y | 5-year | -17.0% | +21.6% | -29.1% | +9.2% |
| alltime | all time | -73.7% | -100.0% | -99.7% | -100.0% |
Celldex Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.38 M(-13.2%) |
| Jun 2024 | - | $1.59 M(-3.3%) |
| Mar 2024 | - | $1.64 M(+1.9%) |
| Dec 2023 | $1.61 M(+11.7%) | $1.61 M(+4.3%) |
| Sep 2023 | - | $1.55 M(+1.1%) |
| Jun 2023 | - | $1.53 M(+2.5%) |
| Mar 2023 | - | $1.49 M(+3.3%) |
| Dec 2022 | $1.45 M(-17.2%) | $1.45 M(+0.5%) |
| Sep 2022 | - | $1.44 M(+0.9%) |
| Jun 2022 | - | $1.43 M(-20.9%) |
| Mar 2022 | - | $1.80 M(+3.2%) |
| Dec 2021 | $1.75 M(+31.6%) | $1.75 M(+27.8%) |
| Sep 2021 | - | $1.37 M(+2.6%) |
| Jun 2021 | - | $1.33 M(-3.0%) |
| Mar 2021 | - | $1.37 M(+3.4%) |
| Dec 2020 | $1.33 M(-31.7%) | $1.33 M(+5.1%) |
| Sep 2020 | - | $1.26 M(-4.3%) |
| Jun 2020 | - | $1.32 M(-21.5%) |
| Mar 2020 | - | $1.68 M(-13.5%) |
| Dec 2019 | $1.94 M(>+9900.0%) | $1.94 M(-13.7%) |
| Sep 2019 | - | $2.25 M(-11.2%) |
| Jun 2019 | - | $2.54 M(-3.6%) |
| Mar 2019 | - | $2.63 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2013 | - | $5.63 M(+0.7%) |
| Dec 2012 | $5.59 M(-8.9%) | $5.59 M(-1.8%) |
| Sep 2012 | - | $5.69 M(+1.1%) |
| Jun 2012 | - | $5.63 M(-0.4%) |
| Mar 2012 | - | $5.65 M(-7.9%) |
| Dec 2011 | $6.14 M(+218.1%) | $6.14 M(+50.0%) |
| Sep 2011 | - | $4.09 M(-18.2%) |
| Jun 2011 | - | $5.00 M(+50.0%) |
| Mar 2011 | - | $3.33 M(+72.8%) |
| Dec 2010 | $1.93 M | $1.93 M(-85.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $13.31 M(+0.6%) |
| Jun 2010 | - | $13.22 M(-7.2%) |
| Mar 2010 | - | $14.25 M(+6124.0%) |
| Sep 2009 | - | $229.00 K(+3.6%) |
| Jun 2009 | - | $221.00 K(+3.5%) |
| Mar 2009 | - | $213.50 K(-2.1%) |
| Dec 2008 | $218.00 K(-54.4%) | $218.00 K(+31.5%) |
| Sep 2008 | - | $165.80 K(+1.2%) |
| Jun 2008 | - | $163.80 K(+1.2%) |
| Mar 2008 | - | $161.80 K(-71.9%) |
| Jun 2007 | - | $575.70 K(+5.3%) |
| Mar 2007 | - | $546.50 K(+14.4%) |
| Dec 2006 | $477.60 K(+119.6%) | $477.60 K(+127.2%) |
| Mar 2006 | - | $210.20 K(-3.4%) |
| Dec 2005 | $217.50 K(+16.6%) | $217.50 K(+16.6%) |
| Dec 2004 | $186.50 K(-32.1%) | $186.50 K(+274.5%) |
| Sep 2001 | - | $49.80 K(-60.1%) |
| Jun 2001 | - | $124.80 K(-37.5%) |
| Mar 2001 | - | $199.60 K(-27.3%) |
| Dec 2000 | $274.50 K(-6.5%) | $274.50 K(-6.5%) |
| Sep 2000 | - | $293.70 K(0.0%) |
| Jun 2000 | - | $293.70 K(0.0%) |
| Mar 2000 | - | $293.70 K(0.0%) |
| Dec 1999 | $293.70 K(-70.6%) | $293.70 K(-70.6%) |
| Sep 1999 | - | $1.00 M(+25.0%) |
| Jun 1999 | - | $800.00 K(-20.0%) |
| Mar 1999 | - | $1.00 M(0.0%) |
| Dec 1998 | $1.00 M(+25.0%) | $1.00 M(+25.0%) |
| Sep 1998 | - | $800.00 K(0.0%) |
| Jun 1998 | - | $800.00 K(0.0%) |
| Mar 1998 | - | $800.00 K(0.0%) |
| Dec 1997 | $800.00 K | $800.00 K(-99.8%) |
| Sep 1997 | - | $401.00 M(+11.9%) |
| Jun 1997 | - | $358.50 M(-5.1%) |
| Mar 1997 | - | $377.70 M |
FAQ
- What is Celldex Therapeutics annual short term debt?
- What is the all time high annual short term debt for Celldex Therapeutics?
- What is Celldex Therapeutics annual short term debt year-on-year change?
- What is Celldex Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly short term debt year-on-year change?
What is Celldex Therapeutics annual short term debt?
The current annual short term debt of CLDX is $1.61 M
What is the all time high annual short term debt for Celldex Therapeutics?
Celldex Therapeutics all-time high annual short term debt is $6.14 M
What is Celldex Therapeutics annual short term debt year-on-year change?
Over the past year, CLDX annual short term debt has changed by +$169.00 K (+11.70%)
What is Celldex Therapeutics quarterly short term debt?
The current quarterly short term debt of CLDX is $1.38 M
What is the all time high quarterly short term debt for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly short term debt is $401.00 M
What is Celldex Therapeutics quarterly short term debt year-on-year change?
Over the past year, CLDX quarterly short term debt has changed by -$235.00 K (-14.56%)